Zobrazeno 1 - 10
of 17
pro vyhledávání: '"I. Raul Badell"'
Publikováno v:
Kidney International Reports, Vol 8, Iss 12, Pp 2529-2545 (2023)
Belatacept is the first costimulatory blockade agent clinically approved for transplant immunosuppression. Although more than 10 years of study have demonstrated that belatacept offers superior long-term renal allograft and patient survival compared
Externí odkaz:
https://doaj.org/article/c18be5862c2043f78b0c94ec30702556
Autor:
Aileen C. Johnson, MD, Geeta M. Karadkhele, MS, Neeta Shenvi, MS, Kirk A. Easley, PhD, Christian P. Larsen, MD, DPhil, I. Raul Badell, MD
Publikováno v:
Transplantation Direct, Vol 9, Iss 3, p e1449 (2023)
Background. Maintenance immunosuppression with belatacept following kidney transplantation results in improved long-term graft function as compared with calcineurin inhibitors. However, broad application of belatacept has been limited, in part relate
Externí odkaz:
https://doaj.org/article/9079cb3d5fcd4fe8998c6d02ff354f0f
Autor:
Emma S. Crichton, MD, MPH, Shan Zeng, MD, PhD, G. Michael La Muraglia, II, PhD, I. Raul Badell, MD
Publikováno v:
Transplantation Direct, Vol 7, Iss 12, p e785 (2021)
Background. Donor-specific antibodies (DSA) are a recognized cause of allograft injury, yet biomarkers that indicate their development posttransplant or guide management are not available. CXCL13 (chemokine [C-X-C motif] ligand 1) is a chemoattractan
Externí odkaz:
https://doaj.org/article/944df3f4cb9c4559bf0b7959bcd41b16
Autor:
Robert Achram, Patricia E. Zerra, Bhaveshkumar Delvadia, Louisa Thompson, I. Raul Badell, John D. Roback, H. Cliff Sullivan
Publikováno v:
Transfusion. 62(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df320b6d0ea42831be3eafbffd9235a3
https://pubmed.ncbi.nlm.nih.gov/36084206
https://pubmed.ncbi.nlm.nih.gov/36084206
Publikováno v:
Transplantation Direct, Vol 7, Iss 12, p e785 (2021)
Transplantation Direct
Transplantation Direct
Supplemental Digital Content is available in the text.
Background. Donor-specific antibodies (DSA) are a recognized cause of allograft injury, yet biomarkers that indicate their development posttransplant or guide management are not available. C
Background. Donor-specific antibodies (DSA) are a recognized cause of allograft injury, yet biomarkers that indicate their development posttransplant or guide management are not available. C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5537d162e69a1d0edd2951c7175047cd
http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001247
http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001247
Autor:
Kirk Easley, Antonio Guasch, Stephen O. Pastan, Christian P. Larsen, Robert A. Bray, Rivka Elbein, Ashtar Chami, Howard M. Gebel, I. Raul Badell, Andrew B. Adams
Publikováno v:
Transplantation. 105(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e1f6306a7a8e6843f4f9cd3934e3679
https://pubmed.ncbi.nlm.nih.gov/34818307
https://pubmed.ncbi.nlm.nih.gov/34818307
Publikováno v:
Curr Transplant Rep
PURPOSE OF REVIEW: Highlight developments in T and B cell biology that are helping elucidate the mechanisms underlying CD28 pathway blockade-mediated inhibition of alloantibodies in transplantation, and discuss recent clinical observations on the imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bbd4f626ef108a25cffca5525b91f0e
https://pubmed.ncbi.nlm.nih.gov/32158639
https://pubmed.ncbi.nlm.nih.gov/32158639
Autor:
Melissa A. Willman, Norma S. Kenyon, Susan A. Safley, Stephanie Duncanson, I. Raul Badell, Collin J. Weber, Dora M. Berman, Athanassios Sambanis, Robert W. Holdcraft, Lawrence S. Gazda, Camillo Ricordi, Neal N. Iwakoshi, Peter Thompson, Graham F. Barber
Publikováno v:
Xenotransplantation. 25(6)
Background Xenogeneic donors would provide an unlimited source of islets for the treatment of type 1 diabetes (T1D). The goal of this study was to assess the function of microencapsulated adult porcine islets (APIs) transplanted ip in streptozotocin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dab67ceb26e174914f027a5f69f9e34
https://pubmed.ncbi.nlm.nih.gov/30117193
https://pubmed.ncbi.nlm.nih.gov/30117193
Publikováno v:
JCI insight. 3(1)
Memory T cells pose a significant problem to successful therapeutic control of unwanted immune responses during autoimmunity and transplantation, as they are differentially controlled by cosignaling receptors such as CD28 and CTLA-4. Treatment with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c59be5b001d948dcb644ca6ed0f230a
https://pubmed.ncbi.nlm.nih.gov/29321374
https://pubmed.ncbi.nlm.nih.gov/29321374
Autor:
I. Raul Badell, Mandy L. Ford
Publikováno v:
Current opinion in organ transplantation. 21(1)
PURPOSE OF REVIEW T follicular helper (Tfh) cells are an increasingly relevant CD4 T cell subset responsible for the provision of help to B cells for the generation of an effective humoral immune response. Here we review recent studies that have prov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2907994a1717f0b9f77db8b3ef53497e
https://pubmed.ncbi.nlm.nih.gov/26727455
https://pubmed.ncbi.nlm.nih.gov/26727455